FDA Approves Celltrion’s New Pediatric Formulation of STEQEYMA, Expanding Dosing Flexibility

June 23, 2025

Alvotech and Teva Announce Acceptance of BLA for AVT05, a Golimumab Biosimilar

January 28, 2025

Recent Ustekinumab and Denosumab Biosimilars Deals

January 7, 2025

FDA Designates Intellia’s Nexiguran Ziclumeran (nex-z) as a Regenerative Medicine Advanced Therapy

December 16, 2024

FDA Accepts BLA for Shanghai Henlius Biotech’s and Organon’s HLX14, a Denosumab Biosimilar

November 7, 2024

Express Scripts Sues FTC Over Report on Pharmacy Benefit Management Industry

October 3, 2024

FDA Issues Draft Guidance on Demonstrating Biosimilar Interchangeability

July 25, 2024

MDL Panel Grants Transfer of Aflibercept BPCIA Case

April 17, 2024

Regeneron Sues Samsung Bioepis for Proposed Biosimilar of EYLEA in West Virginia District Court

November 28, 2023

UK Authorizes World-First Gene Therapy from Vertex and CRISPR Therapeutics for Blood Disorders

November 16, 2023